Literature DB >> 10992523

Purification and characterization of a cytotonic protein expressed In vitro by the live cholera vaccine candidate CVD 103-HgR.

V Sathyamoorthy1, R H Hall, B A McCardell, M H Kothary, S J Ahn, S Ratnayake.   

Abstract

Cholera vaccines developed by the deletion of CTX genes from Vibrio cholerae induce a residual reactogenicity in up to 10% of vaccinees. A novel cytotonic agent named secreted CHO cell elongating protein (S-CEP) was purified from culture supernatants of CVD 103-HgR (Levine et al., Lancet ii:467-470, 1988). Five fractionation steps yielded electrophoretically pure S-CEP with an M(r) of 79,000. A partially purified preparation caused fluid accumulation in the sealed infant mouse model. The amino terminus bore a unique sequence with strong homology to a cytotonic toxin of El Tor V. cholerae.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992523      PMCID: PMC101575          DOI: 10.1128/IAI.68.10.6062-6065.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice.

Authors:  V Baselski; R Briggs; C Parker
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  Identification of a CHO cell-elongating factor produced by Vibrio cholerae O1.

Authors:  B A McCardell; M H Kothary; R H Hall; V Sathyamoorthy
Journal:  Microb Pathog       Date:  2000-07       Impact factor: 3.738

4.  Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development.

Authors:  J J Mekalanos; D J Swartz; G D Pearson; N Harford; F Groyne; M de Wilde
Journal:  Nature       Date:  1983 Dec 8-14       Impact factor: 49.962

5.  The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil.

Authors:  M M Levine; R E Black; M L Clements; L Cisneros; A Saah; D R Nalin; D M Gill; J P Craig; C R Young; P Ristaino
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

6.  Purification and characterization of novel toxin produced by Vibrio cholerae O1.

Authors:  K Walia; S Ghosh; H Singh; G B Nair; A Ghosh; G Sahni; H Vohra; N K Ganguly
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: another toxic substance produced by cholera vibrios.

Authors:  T Honda; R A Finkelstein
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

8.  Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates.

Authors:  J B Kaper; H Lockman; M M Baldini; M M Levine
Journal:  Nature       Date:  1984 Apr 12-18       Impact factor: 49.962

9.  Fluid accumulation in infant mice caused by Vibrio hollisae and its extracellular enterotoxin.

Authors:  M H Kothary; S H Richardson
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

10.  Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.